ERBB2 and breast cancer: Although PPS does not provide better risk discriminatory ability in predicting prognosis than AS in patients with node-positive HoR+/HER2+ BC after mastectomy, PPS is valuable in providing prognostic counseling to patients and may also guide PMRT decision-making.